The Uromigos Episode 157: ASCO GU 2022 Sacituzumab and Pembrolizumab in Bladder Cancer

By The Uromigos - Last Updated: February 18, 2022

Dr Petros Grivas describes the results of the phase 2 trial of sacituzumab and pembrolizumab in bladder cancer presented at the 2022 ASCO GU Symposium.

Post Tags:Uromigos-ASCO GU
Did you like this article?